...
首页> 外文期刊>Pediatrics: Official Publication of the American Academy of Pediatrics >Antibody Response of Low Birth Weight Infants to Haemophilus influenzae Type b Polyribosylribitol Phosphate-Outer Membrane Protein Conjugate Vaccine
【24h】

Antibody Response of Low Birth Weight Infants to Haemophilus influenzae Type b Polyribosylribitol Phosphate-Outer Membrane Protein Conjugate Vaccine

机译:低出生体重儿对b型流感嗜血杆菌的多核糖基核糖醇磷酸-外膜蛋白结合疫苗的抗体应答

获取原文
           

摘要

Objective . To evaluate the effectiveness in low birth weight (LBW) infants of the currently recommended immunization schedule for conjugated Haemophilus influenzae type b (HIB) vaccine.Methods . We quantified antibody responses in 36 preterm infants with a mean birth weight of 1060 g and a mean gestational age of 28 weeks. Infants were immunized with 0.5 mL of HIB vaccine at 2 and 4 months' postnatal age. Specific HIB antibodies were quantified on cord blood, immediately before each immunization and 2 months after the last immunization.Results . Even though the geometric mean titers increased significantly during the study period, they were still markedly lower than values reported in term infants. After the second immunization, only 24 infants (67%) attained antibody concentrations of more than 0.25 μg/mL, defined as seropositivity. Also, only 53% of infants achieved antibody concentrations of more than 1.0 μg/mL compared with 92% as reported in term infants. Stepwise logistic regression identified gestational age of 27 weeks or less and the amount of intravenous immunoglobulin received as the significant variables influencing the antibody response after the first immunization. The incidence of side effects was negligible.Conclusions . We conclude that LBW infants, and especially those born at 27 or less weeks' gestation, do not respond as effectively to the HIB vaccine. We speculate that reevaluation of the current immunization schedule may be required for very LBW infants.
机译:目标。为了评估目前推荐的b型流感嗜血嗜血杆菌(HIB)疫苗免疫方案在低出生体重(LBW)婴儿中的有效性。我们对36名平均出生体重为1060 g,平均胎龄为28周的早产儿的抗体反应进行了量化。在出生后2个月和4个月时,用0.5 mL的HIB疫苗对婴儿进行免疫。每次免疫前和最后一次免疫后2个月,在脐带血上定量特异性HIB抗体。尽管在研究期间几何平均滴度明显增加,但仍明显低于足月婴儿报告的数值。第二次免疫后,只有24例婴儿(67%)获得的抗体浓度超过0.25μg/ mL,这被定义为血清阳性。此外,只有53%的婴儿达到的抗体浓度超过1.0μg/ mL,而足月婴儿中报告的这一比例为92%。逐步logistic回归确定胎龄为27周或更短,静脉注射免疫球蛋白的量是影响首次免疫后抗体反应的重要变量。副作用的发生可以忽略。我们得出的结论是,LBW婴儿,尤其是那些在怀孕27周或更短的一周内出生的婴儿,对HIB疫苗的反应不那么有效。我们推测,极低出生体重的婴儿可能需要重新评估当前的免疫计划。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号